Position history for FRONTIER CAPITAL MANAGEMENT CO LLC's holdings in BRIDGEBIO PHARMA INC
FRONTIER CAPITAL MANAGEMENT CO LLC holds 826,131 shares of BBIO (BRIDGEBIO PHARMA INC), worth $63.2M as of 2025-Q4. The position was increased (++25.2% shares). BBIO represents 0.7% of FRONTIER CAPITAL MANAGEMENT CO LLC's portfolio.
Current Value
$63.2M
Current Shares
826,131
Total Value Change
+$59.4M
Total Shares Change
+677,763
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 826,131 |
+25.2% |
| $63.2M |
| 0.7% |
| $75.48 |
51 |
| 2025-Q3 | Increased | 659,633 | +23.1% | $34.3M | 0.3% | $51.96 | 42 |
| 2025-Q2 | Decreased | 535,763 | -30.4% | $23.1M | 0.2% | $44.86 | 0 |
| 2025-Q1 | Decreased | 769,301 | -28.5% | $26.6M | 0.3% | $35.11 | 0 |
| 2024-Q4 | Increased | 1.1M | +113.8% | $29.5M | 0.3% | $27.32 | 56 |
| 2024-Q3 | Increased | 503,162 | +239.1% | $12.8M | 0.1% | $24.94 | 54 |
| 2024-Q2 | Decreased | 148,368 | -67.0% | $3.8M | 0.0% | $25.33 | 0 |